Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us dr. M.G.S. (Martijn) Rutten
University Medical Center Groningen

dr. M.G.S. (Martijn) Rutten

PostDoctoral Researcher
Profile picture of dr. M.G.S. (Martijn) Rutten
E-mail:
m.g.s.rutten umcg.nl

Publications

Hepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice

Sport and longevity: an observational study of international athletes

Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib (6675 words)

C/EBPβ-LIP mediated activation of the malate-aspartate shuttle sensitizes cells to glycolysis inhibition

Functional Validation of the Putative Oncogenic Activity of PLAU

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia

Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a

Understanding hepatic Glycogen Storage Disease type Ia: role of phenotypic heterogeneity and nutrient sensors

Disrupted glucose-6-phosphate-ChREBP signalling aggravates hepatomegaly and accelerates liver disease progression in a mouse model for Glycogen Storage Disease type 1a

Sustainable Development Goals

SDG 3 - Good Health and Well-being

More information about the Sustainable Development Goals.